Delivery Order SPE2DB24D9228-SPE2DB25FATHQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order employs firm fixed-price terms and represents a standard procurement action within the agency's pharmaceutical supply operations....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $22,268.40 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with an ultimate completion date of September 12, 2025. This delivery order was awarded on August 21, 2025, without a set-aside designation, allowing the vendor to compete on an...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on August 5, 2025, for the supply of YF-VAX 1 dose vials with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a straightforward pharmaceutical procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work...
- The Defense Logistics Agency awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of September 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract employs firm fixed-price pricing and represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $15,031.17 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 21, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, Illinois, and represents a continuation of the company's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,783.55 by the Defense Logistics Agency on July 25, 2025, for YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials on August 28, 2025. This firm fixed-price delivery order, which is expected to be completed by September 19, 2025, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the woman-owned small business to compete directly in the federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. on August 19, 2025, for the provision of YF-VAX 1 dose vials, a yellow fever vaccine product. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, was issued without a set-aside designation. Performance will take place at DMS Pharmaceutical Group's facility in Park Ridge, Illinois. The contract represents a discrete fulfillment under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, a yellow fever vaccine product. The contract, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, operates under a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois...
- SPE2DB24D9228Indefinite Delivery Contract
- SPE2DB24D9228-SPE2DB25FATHQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was awarded on September 8, 2025, with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility. The company has been registered in the System for Award Management since 2001 and specializes in providing comprehensive pharmaceutical products and medical supplies to federal agencies, particularly Department of Defense healthcare systems. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items supporting medical supply needs across military health facilities worldwide. YF-VAX, a yellow fever vaccine, represents one of many specialized pharmaceutical products the contractor supplies through this strategic vehicle, which encompasses branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. This contract positioning establishes DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/8/25 |